Newsletter | March 7, 2024

03.07.24 -- Trends In FDA FY2023 Inspection-Based Warning Letters

SPONSOR

INTERPHEX is back in New York with exciting show features. This includes a BRAND-NEW Conference Program! The INTERPHEX Conference will unfold in the Learning Lab on the Exhibit Hall floor of INTERPHEX. It will feature peer-reviewed scientific presentations that examine quality systems, contamination control strategies for cell and gene therapies, 3D bioprinting, AI applications for formulations, and U.S. FDA regulatory updates, among other hot industry topics. Register today.

FEATURED EDITORIAL

Trends In FDA FY2023 Inspection-Based Warning Letters

The U.S. FDA issued 180 warning letters to drug and biologics manufacturers in fiscal year 2023 (FY23), and 94 of them were based on an on-site inspection of the company. This article provides an analysis of trends and observations from the inspection-based letters, as well as additional insight into the agency’s approach to enforcement.

INDUSTRY INSIGHTS

4 Factors To Consider When Scaling Up

It's essential to understand how scaling up affects your aseptic filling operations. Here are four topics to consider to help ensure your drug product will be taken care of and ready for production.

Placing Patients At The Center Of Drug Design

Experts discuss the best time to start thinking about patient centricity, the steps developers can take to achieve patient-centric drug design, and how formulation and dosage forms can make a difference.

The Impact Of Water Activity Testing On Tablets And Capsules

Watch to gain a comprehensive understanding of water activity testing as well as how to effectively use nondestructive headspace analysis to generate dependable water activity data.

A Globally Unique Capability For Nanoforming HPAPIs

As demand for high-potency active pharmaceutical ingredients (HPAPIs) rises, ensuring your company utilizes specialized facilities with HPAPI handling capabilities is crucial.

Tackling The Drug Development Crisis Using Improved Preclinical Models

The productivity of drug development has sharply declined over the past seven decades. Discover how improving preclinical models holds the key to solving the challenge at the heart of drug development.

FAT, SAT, IQ, OQ, SMEPAC: What Does It All Really Mean?

Gain insight into the proper timeline for process validation, the importance of linking the user requirements specification (URS) to each step of validation to ensure complete compliance, and more.

Software Validation Keeps GxP Systems Current, Speeds Up Time-To-Market

Requirements to maintain a GxP environment mean researchers must conduct software validation on any updated software so that it continues to meet users’ needs.

Recommended Mixing Technologies For Producing Capsule Shells

Learn how you can simplify mixer selection for a particular capsule shell formulation by considering the formulation's viscosity and the appropriate level of shear.

Wearable Injectors: An Alternative To Traditional Intravenous Administration

See a quick visual summary of findings from an early feasibility clinical study featuring a 2-5 mL wearable injector with a viscous placebo.

Empowering Healthcare With Innovative Medical Polyurethanes

Gain insights into how medical polyurethanes are enhancing medical devices, improving patient outcomes, and driving innovation in the healthcare industry.

Key Offerings To Help Support Your OSD On Its Journey To Market

Examine several important factors needed to effectively support oral solid dosage therapeutic manufacturing and overcome the complexities involved.

The Benefits Of Downstream Process Connection Technology

Single-use downstream applications including chromatography, filtration, and purification create difficult environments for supplier components due to the presence of chemicals across a wide pH range. 

Moving The Needle: A Final Filling Case Study Webinar

Watch this webinar to hear about a collaboration that helped optimize their new filling line with single-use needles and reduced downtime.

Onshoring Pharmaceutical Manufacturing: The Right CMO Partner

When drug and API manufacturers decide to make the shift to bring production back to the U.S., they should be prepared with a well-designed quality system and a thorough tech transfer process.

Cleaning Proteins, RNA, And DNA From Lab Equipment

Learn about three of the best methods for cleaning proteins, RNA, and DNA from laboratory equipment.

SimpliFiH Solutions For Accelerated Pharmaceutical Development

Explore an integrated service package designed to simplify and accelerate the development pathway, even for APIs with challenging properties such as low aqueous solubility and poor bioavailability.

SOLUTIONS

Vision Robot Unit: Driving Pharma Innovation

Blow/Fill/Seal Packaging Systems

Dynamic Vapor Sorption Analyzer

Annex 1 Ready Cleanroom Classification Testing

Vaccine API Weighing And Processing Glovebox Workstation

Contract Packaging Services For Probiotics

Connect With Pharmaceutical Online: